NATACYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Natacyn, and when can generic versions of Natacyn launch?
Natacyn is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in NATACYN is natamycin. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the natamycin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NATACYN?
- What are the global sales for NATACYN?
- What is Average Wholesale Price for NATACYN?
Summary for NATACYN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 4,255 |
| Drug Prices: | Drug price information for NATACYN |
| What excipients (inactive ingredients) are in NATACYN? | NATACYN excipients list |
| DailyMed Link: | NATACYN at DailyMed |
Pharmacology for NATACYN
| Drug Class | Polyene Antimicrobial |
US Patents and Regulatory Information for NATACYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | NATACYN | natamycin | SUSPENSION;OPHTHALMIC | 050514-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
